Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study

Aims. New-onset type 1 diabetes mellitus (T1D) in pediatric patients represents a clinical challenge for initial total daily insulin dosing (TIDD) due to substantial heterogeneity in practice and lack of consensus on the optimal starting dose. Our INSENODIAB (INsulin SEnsitivity in New Onset type 1...

Full description

Saved in:
Bibliographic Details
Main Authors: Maude Beckers, Olivier Polle, Paola Gallo, Noémie Bernard, Céline Bugli, Philippe A. Lysy
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2023/5568663
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546644757839872
author Maude Beckers
Olivier Polle
Paola Gallo
Noémie Bernard
Céline Bugli
Philippe A. Lysy
author_facet Maude Beckers
Olivier Polle
Paola Gallo
Noémie Bernard
Céline Bugli
Philippe A. Lysy
author_sort Maude Beckers
collection DOAJ
description Aims. New-onset type 1 diabetes mellitus (T1D) in pediatric patients represents a clinical challenge for initial total daily insulin dosing (TIDD) due to substantial heterogeneity in practice and lack of consensus on the optimal starting dose. Our INSENODIAB (INsulin SEnsitivity in New Onset type 1 DIABetes) study is aimed at (1) exploring the influence of patient-specific characteristics on insulin requirements in pediatric patients with new-onset T1D; (2) constructing a predictive model for the recommended TIDD tailored to individual patient profiles; and (3) assessing potential associations between TIDD and patient outcomes at follow-up intervals of 3 and 12 months. Methods. We conducted a comprehensive analysis of medical records for children aged 6 months to 18 years, hospitalized for new-onset T1D from 2013 to 2022. The study initially involved multivariable regression analysis on a retrospective cohort (rINSENODIAB), incorporating baseline variables. Subsequently, we validated the model robustness on a prospective cohort (pINSENODIAB) with a significance threshold of 5%. The model accuracy was assessed by Pearson’s correlation. Results. Our study encompassed 103 patients in the retrospective cohort and 80 in the prospective cohort, with median TIDD at diagnosis of 1.1 IU/kg BW/day (IQR 0.5). The predictive model for optimal TIDD was established using baseline characteristics, resulting in the following formula: TIDD IU/d=0.09×Age2+0.68×%Weight Loss+28.60×Veinous pH−1.03×Veinous bicarbonates+0.81×Weight−194.63. Validation of the model using the pINSENODIAB cohort demonstrated a significant Pearson correlation coefficient of 0.74. Notably, no significant correlation was observed between TIDD at diagnosis and partial remission markers (IDAA1C, C-peptide) at 3- and 12-months postdiagnosis time points. Conclusions. In the context of new-onset T1D in pediatric patients, we identified key influencing factors for determining optimal TIDD, including age, percentage of weight loss, weight, veinous pH, and bicarbonates. These findings have paved the way for the development of a dosing algorithm to potentially expedite glycemic control stabilization and facilitate a more individualized approach to treatment regimens.
format Article
id doaj-art-104dd7c18356439083baa905352dc98e
institution Kabale University
issn 2314-6753
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-104dd7c18356439083baa905352dc98e2025-02-03T06:47:35ZengWileyJournal of Diabetes Research2314-67532023-01-01202310.1155/2023/5568663Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB StudyMaude Beckers0Olivier Polle1Paola Gallo2Noémie Bernard3Céline Bugli4Philippe A. Lysy5Paediatric Endocrinology and Diabetes UnitPaediatric Endocrinology and Diabetes UnitPaediatric Endocrinology and Diabetes UnitPaediatric Endocrinology and Diabetes UnitLouvain School of StatisticsPaediatric Endocrinology and Diabetes UnitAims. New-onset type 1 diabetes mellitus (T1D) in pediatric patients represents a clinical challenge for initial total daily insulin dosing (TIDD) due to substantial heterogeneity in practice and lack of consensus on the optimal starting dose. Our INSENODIAB (INsulin SEnsitivity in New Onset type 1 DIABetes) study is aimed at (1) exploring the influence of patient-specific characteristics on insulin requirements in pediatric patients with new-onset T1D; (2) constructing a predictive model for the recommended TIDD tailored to individual patient profiles; and (3) assessing potential associations between TIDD and patient outcomes at follow-up intervals of 3 and 12 months. Methods. We conducted a comprehensive analysis of medical records for children aged 6 months to 18 years, hospitalized for new-onset T1D from 2013 to 2022. The study initially involved multivariable regression analysis on a retrospective cohort (rINSENODIAB), incorporating baseline variables. Subsequently, we validated the model robustness on a prospective cohort (pINSENODIAB) with a significance threshold of 5%. The model accuracy was assessed by Pearson’s correlation. Results. Our study encompassed 103 patients in the retrospective cohort and 80 in the prospective cohort, with median TIDD at diagnosis of 1.1 IU/kg BW/day (IQR 0.5). The predictive model for optimal TIDD was established using baseline characteristics, resulting in the following formula: TIDD IU/d=0.09×Age2+0.68×%Weight Loss+28.60×Veinous pH−1.03×Veinous bicarbonates+0.81×Weight−194.63. Validation of the model using the pINSENODIAB cohort demonstrated a significant Pearson correlation coefficient of 0.74. Notably, no significant correlation was observed between TIDD at diagnosis and partial remission markers (IDAA1C, C-peptide) at 3- and 12-months postdiagnosis time points. Conclusions. In the context of new-onset T1D in pediatric patients, we identified key influencing factors for determining optimal TIDD, including age, percentage of weight loss, weight, veinous pH, and bicarbonates. These findings have paved the way for the development of a dosing algorithm to potentially expedite glycemic control stabilization and facilitate a more individualized approach to treatment regimens.http://dx.doi.org/10.1155/2023/5568663
spellingShingle Maude Beckers
Olivier Polle
Paola Gallo
Noémie Bernard
Céline Bugli
Philippe A. Lysy
Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study
Journal of Diabetes Research
title Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study
title_full Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study
title_fullStr Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study
title_full_unstemmed Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study
title_short Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study
title_sort determinants and characteristics of insulin dose requirements in children and adolescents with new onset type 1 diabetes insights from the insenodiab study
url http://dx.doi.org/10.1155/2023/5568663
work_keys_str_mv AT maudebeckers determinantsandcharacteristicsofinsulindoserequirementsinchildrenandadolescentswithnewonsettype1diabetesinsightsfromtheinsenodiabstudy
AT olivierpolle determinantsandcharacteristicsofinsulindoserequirementsinchildrenandadolescentswithnewonsettype1diabetesinsightsfromtheinsenodiabstudy
AT paolagallo determinantsandcharacteristicsofinsulindoserequirementsinchildrenandadolescentswithnewonsettype1diabetesinsightsfromtheinsenodiabstudy
AT noemiebernard determinantsandcharacteristicsofinsulindoserequirementsinchildrenandadolescentswithnewonsettype1diabetesinsightsfromtheinsenodiabstudy
AT celinebugli determinantsandcharacteristicsofinsulindoserequirementsinchildrenandadolescentswithnewonsettype1diabetesinsightsfromtheinsenodiabstudy
AT philippealysy determinantsandcharacteristicsofinsulindoserequirementsinchildrenandadolescentswithnewonsettype1diabetesinsightsfromtheinsenodiabstudy